medigraphic.com
SPANISH

Revista de Nefrología, Diálisis y Trasplante

ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 1

<< Back Next >>

Rev Nefrol Dial Traspl 2025; 45 (1)

Sarcopenia, Depression, and Chronic Inflammation, factors associated with Frailty in Older Adults on chronic hemodialysis in a hospital in the south of Chile

Álvarez M, Deleón R, Vergara M, Vera S, Paredes P, Negrón R
Full text How to cite this article

Language: Spanish
References: 37
Page: 3-12
PDF size: 318.27 Kb.


Key words:

Nephrogeriatrics, frailty, dialysis, sarcopenia, chronic kidney failure.

ABSTRACT

Introduction: Chile has the highest prevalence of hemodialysis patients in South America, with 1260 patients per million inhabitants, 56% of whom are older adults. Currently, the prevalence of frailty in this group is unknown in Latin America. Objective: Determine the frailty of older adults on chronic hemodialysis at Angol Hospital and identify associated factors. Material and Methods: This is an observational, quantitative, and cross-sectional study, applying the FRAIL test as a diagnostic tool for frailty. Screening for depressive symptoms was carried out using the PHQ9 test, measurement of inflammatory status with the Malnutrition Inflammation Score (MIS), and evaluation of subjective quality of life with the Edmonton Symptom Assessment System Revised Renal (ESAS-r: Renal) test. In parallel, a Sarcopenia screening was carried out using bioimpedance following the criteria of the European Working Group on Sarcopenia in Older People. Results: 32 older adults on dialysis were evaluated. The prevalence of frailty was 25% (n=8). The presence of severe sarcopenia (p 0.00), history of falls in the last 6 months (p 0.00), elevated Parathyroid hormone levels (p 0.04), and poor performance on the Short Physical Performance Battery was associated with frailty (p 0.00), and elevated inflammation markers through the Malnutrition Inflammation Score (p 0.00). Frail patients scored higher in the subjective quality of life test Edmonton Symptom Assessment System- Renal (21, 8 vs. 47.5 p 0.00) and PHQ9 (7.5± 6.0 vs 3.8± 3.0 p: 0.01). Discussion: The prevalence was somewhat lower than the reported in the literature; however, phenotypically, it corresponds to a high-risk profile: sarcopenic, with a poor quality of life and marked by a pro-inflammatory microenvironment.


REFERENCES

  1. Zavala de Cosío, M. E., (1995). Dos modelos detransición demográfica en América Latina. PerfilesLatinoamericanos, (6),29-47.[fecha de Consulta 14de Enero de 2025]. ISSN: 0188-7653. Recuperado de:https://www.redalyc.org/articulo.oa?id=11560403

  2. Albala C. The aging of the Chilean population andthe challenges for health and wellbeing of olderpeople. Revista Médica Clínica Las Condes. 2020Jan 1;31(1):7–12.

  3. Comisión Económica para América Latina y elCaribe (CEPAL), Observatorio Demográfico, 2024,(LC/PUB.2024/22-P), Santiago, 2024.

  4. Turra C, Fernándes F. La transición demográficaOportunidades y desafíos en la senda hacia ellogro de los Objetivos de Desarrollo Sostenible enAmérica Latina y el Caribe. Comisión Económicapara América Latina y el Caribe (CEPAL) [Internet].2021;1–85. Available from: www.cepal.org/apps

  5. Subdepartamento Demografía-INE. Boletíndemográfico anual provisional de estadísticasvitales 2023 [Internet]. 2024 Mar [cited 2024Aug 30]. Available from: https://www.ine.gob.cl/docs/default-source/nacimientos-matrimonios-ydefunciones/publicaciones-y-anuarios/anuarios-deestad%C3%ADsticas-vitales/estad%C3%ADsticasvitales-cifras-provisionales-2023.pdf?sfvrsn=806c0479_9

  6. Instituto Nacional de Estadísticas Chile. Boletínestadístico: estadísticas vitales coyunturales[Internet]. 2024 Aug [cited 2024 Aug 30]. Availablefrom: https://www.ine.gob.cl/docs/defaultsource/nacimientos-matrimonios-y-defunciones/boletines/2024/estad%C3%ADsticas-vitales-cifrascoyunturales-junio-2024.pdf?sfvrsn=7be10848_9

  7. Flores JC, Alvo M, Borja H, Morales J, Vega J, ZúñigaC, et al. Sociedad Chilena de Nefrología Enfermedadrenal crónica: Clasificación, identificación, manejo ycomplicaciones. Vol. 137, Rev. Méd. Chile. 2004.

  8. Torales, S., Vallejos, A., Valenti, L., & Programade Abordaje Integral de Enfermedades Renales(PAIER), Instituto Nacional Central ÚnicoCoordinador de Ablación e Implante (INCUCAI),Ministerio de Salud de la Nación, Argentina. (2018).Hacia un nuevo paradigma en el abordaje de laenfermedad renal crónica avanzada. In Rev ArgentSalud Pública (Vols. 9–35, pp. 33–37).

  9. Poblete H. XLIII CUENTA DE HEMODIÁLSISCRÓNICA [Internet]. 2023 [cited 2024 Jan 25].Available from: https://nefro.cl/web/biblioteca_c.php

  10. Marinovich y cols. Sociedad Argentina de Nefrología(SAN). 2023 [cited 2025 Jan 13]. p. 1–370 RegistroArgentino de Diálisis Crónica 2022 Informe 2023.Available from: https://www.cadradialisis.org.ar/descargas/registro/Registro%20Argentino%20de%20Dialisis%20Cronica%202022%20SAN%20-%20INCUCAI.pdf

  11. Carlota González-Bedat M, Luzardo L, MaríaVO, Ceretta L, Silvariño R, Ferreiro A. RegistroUruguayo Diálisis. Informe Anual [Internet].2019 [cited 2024 Aug 30]. p. 1–82. Availablefrom: https://www.nefrologia.hc.edu.uy/images/INFORME_2019_FINAL_1.pdf

  12. Kishi S, Kadoya H, Kashihara N. Treatment ofchronic kidney disease in older populations. NatRev Nephrol [Internet]. 2024 Jul 8; Available from:https://www.nature.com/articles/s41581-024-00854-w12) Kishi S, Kadoya H, Kashihara N. Treatment ofchronic kidney disease in older populations. Nat RevNephrol [Internet]. 2024 Jul 8; Available from: https://www.nature.com/articles/s41581-024-00854-w

  13. Fried LP, Tangen CM, Walston J, Newman AB,Hirsch C, Gottdiener J, et al. Frailty in Older Adults:Evidence for a Phenotype [Internet]. Vol. 56, Journalof Gerontology: medical sciences. Copyright.2001. Available from: https://academic.oup.com/biomedgerontology/article/56/3/M146/545770

  14. Lam de Calvo O. Fisiología del síndrome de fragilidaden el adulto mayor. Revista Médico Científica.2007;20(1):31–5.

  15. Zhang F, Wang H, Bai Y, Zhang Y, Huang L, ZhangH. Prevalence of physical frailty and impact onsurvival in patients with chronic kidney disease: asystematic review and meta-analysis. BMC Nephrol.2023 Dec 1;24(1).

  16. Gordon Chun-Kau Chan, Kamyar Kalantar-Zadeh,Jack Kit-Chung Ng, Na Tian, Aine Burns, Kai-MingChow, et al. Frailty in patients on dialysis. Kidney Int.2024;106:35–49.

  17. Sukkriang, N., & Punsawad, C. (2020). Comparisonof geriatric assessment tools for frailty amongcommunity elderly. Heliyon, 6(9), e04797. https://doi.org/10.1016/j.heliyon.2020.e04797

  18. Davison SN, Jhangri GS, Johnson JA. Longitudinalvalidation of a modified Edmonton symptomassessment system (ESAS) in haemodialysispatients. Nephrology Dialysis Transplantation. 2006Nov;21(11):3189–95.

  19. Baader M, Molina J, Venezian S, Rojas C, FaríasR, Fierro-Freixenet C, et al. Validación y utilidad dela encuesta PHQ-9 (Patient Health Questionnaire)en el diagnóstico de depresión en pacientes usuariosde atención primaria en Chile. Rev. Chil. Neuropsiquiatía. 2012;50(1):10–22.

  20. Saldivia S, Aslan J, Cova F, Vicente B, InostrozaC, Rincón P. Propiedades psicométricas del PHQ-9(Patient Health Questionnaire) en centros de atenciónprimaria de Chile. Psychometric characteristics ofthe Patient Health Questionnaire (PHQ-9). Vol. 147,Rev Med Chile. 2019.

  21. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y,Bruyère O, Cederholm T, et al. Sarcopenia: RevisedEuropean consensus on definition and diagnosis.Vol. 48, Age and Ageing. Oxford University Press;2019. p. 16–31.

  22. Nogueira Á, Álvarez G, Russo F, San-José B,Sánchez-Tomero JA, Barril G. ¿Es útil el SPPB comométodo de screening de capacidad funcional enpacientes con enfermedad renal crónica avanzada?Nefrología. 2019 Sep;39(5):489–96.

  23. Kalantar-Zadeh K, Kopple JD, Humphreys MH,Block G. Comparing outcome predictability ofmarkers of malnutrition-inflammation complexsyndrome in hemodialysis patients. NephrologyDialysis Transplantation. 2004 Jun;19(6):1507–19.

  24. Lee HJ, Son YJ. Prevalence and associated factorsof frailty and mortality in patients with end-stagerenal disease undergoing hemodialysis: A systematicreview and meta-analysis. Vol. 18, InternationalJournal of Environmental Research and PublicHealth. MDPI AG; 2021.

  25. Díaz-Toro F, Nazar G, Troncoso C, Concha-Cisternas Y, Leiva-Ordoñez AM, Martínez-Sanguinetti MA, et al. Frailty Index as a Predictorof Mortality in Middle-Aged and Older People:A Prospective Analysis of Chilean Adults. Int J.Environ Res Public Health. 2023 Jan 1;20(2).

  26. Negrón R, Deleón R, Vergara M, Paredes P, ÁlvarezM. Prevalencia de depresión en un grupo de adultosmayores en Hemodiálisis crónica del Hospital deAngol. Rev. Chil. Neuro-psiquiatría [Internet]. 2024[cited 2024 Jul 24];62(2):143–9. Available from:https://www.scielo.cl/pdf/rchnp/v62n2/0717-9227-rchnp-62-02-0143.pdf

  27. Daugirdas, J., Blake, P., & Ing, T. (2015). Handbookof Dialysis. In Chronic Kidney Disease Management(5th ed.). Wolkers Kluwer.

  28. Davison SN, Jhangri GS. The impact of chronicpain on depression, sleep, and the desire to withdrawfrom dialysis in hemodialysis patients. J PainSymptom Manage. 2005 Nov;30(5):465–73.

  29. Stevens PE, Ahmed SB, Carrero JJ, Foster B, FrancisA, Hall RK, et al. KDIGO 2024 Clinical PracticeGuideline for the Evaluation and Management ofChronic Kidney Disease. Kidney Int. 2024 Apr1;105(4):S117–314.

  30. Pan L, Xie W, Fu X, Lu W, Jin H, Lai J, et al.Inflammation and sarcopenia: A focus on circulatinginflammatory cytokines. Vol. 154, ExperimentalGerontology. Elsevier Inc.; 2021.

  31. de Oliveira EM, da Silva RP, de Lemos M da CC,Burgos MGP de A, Costa DMN, Maio R. Frequencyof sarcopenia, cachexia, and associated factors inpatients with chronic kidney disease in dialysistreatment. Nutrición Hospitalaria. 2020 Nov1;37(6):1157–65.

  32. Sá Martins V, Aguiar L, Dias C, Lourenço P,Pinheiro T, Velez B, et al. Predictors of nutritionaland inflammation risk in hemodialysis patients.Clinical Nutrition. 2020 Jun 1;39(6):1878–84.

  33. Müller-Ortiz H, Pedreros-Rosales C, Vera-Calzaretta A, González-Burbuoa A, Zúñiga-SanMartín C, Oliveros-Romero MS. Entrenamientofísico en personas con enfermedad renal crónicaavanzada: beneficios de su implementación enla práctica clínica. Rev. Med. Chile [Internet].2019;147:1443–8. Available from: https://www.nefro.cl/v2/biblio/registro/24.

  34. Álvarez M, Negrón R, Neira-Maldonado C, Ponce-Fuentes F, Cuyul-Vásquez I. Fasting Glycemia,Glycosylated Hemoglobin and MalnutritionInflammation Are Associated with Sarcopeniain Older People with Chronic Kidney DiseaseUndergoing Hemodialysis Treatment: A Cross-Sectional Study. Cureus [Internet]. 2024 Nov25; Available from: https://www.cureus.com/articles/318407-fasting-glycemia-glycosylatedhemoglobin-and-malnutrition-inflammation-areassociated-with-sarcopenia-in-older-people-withchronic-kidney-disease-undergoing-hemodialysistreatment-a-cross-sectional-study

  35. Villanego F, Naranjo J, Vigara LA, Cazorla JM,Montero ME, García T, et al. Impacto del ejerciciofísico en pacientes con enfermedad renal crónica:revisión sistemática y metaanálisis. Nefrología.2020 May;40(3):237–52.

  36. Fouque D, Kalantar-Zadeh K, Kopple J, CanoN, Chauveau P, Cuppari L, et al. A proposednomenclature and diagnostic criteria for proteinenergywasting in acute and chronic kidney disease.In: Kidney International. Nature Publishing Group;2008. p. 391–8.

  37. Fernández Soto ML, González Jiménez A. Valoracióny soporte nutricional en la Enfermedad RenalCrónica. Nutr. Clin. Med. 2014; VIII (3):136–53.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Nefrol Dial Traspl. 2025;45